GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Advanced Enzyme Technologies Ltd (BOM:540025) » Definitions » Debt-to-EBITDA

Advanced Enzyme Technologies (BOM:540025) Debt-to-EBITDA : 0.00 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Advanced Enzyme Technologies Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Advanced Enzyme Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Advanced Enzyme Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Advanced Enzyme Technologies's annualized EBITDA for the quarter that ended in Dec. 2023 was ₹2,726 Mil. Advanced Enzyme Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Advanced Enzyme Technologies's Debt-to-EBITDA or its related term are showing as below:

BOM:540025' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.12   Med: 0.27   Max: 3.52
Current: 0.17

During the past 13 years, the highest Debt-to-EBITDA Ratio of Advanced Enzyme Technologies was 3.52. The lowest was 0.12. And the median was 0.27.

BOM:540025's Debt-to-EBITDA is ranked better than
88.6% of 1211 companies
in the Chemicals industry
Industry Median: 2.28 vs BOM:540025: 0.17

Advanced Enzyme Technologies Debt-to-EBITDA Historical Data

The historical data trend for Advanced Enzyme Technologies's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Enzyme Technologies Debt-to-EBITDA Chart

Advanced Enzyme Technologies Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.16 0.12 0.17 0.19

Advanced Enzyme Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.16 - 0.17 -

Competitive Comparison of Advanced Enzyme Technologies's Debt-to-EBITDA

For the Specialty Chemicals subindustry, Advanced Enzyme Technologies's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Enzyme Technologies's Debt-to-EBITDA Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Advanced Enzyme Technologies's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Advanced Enzyme Technologies's Debt-to-EBITDA falls into.



Advanced Enzyme Technologies Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Advanced Enzyme Technologies's Debt-to-EBITDA for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(111.22 + 223.77) / 1778.38
=0.19

Advanced Enzyme Technologies's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / 2726.28
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Advanced Enzyme Technologies  (BOM:540025) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Advanced Enzyme Technologies Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Advanced Enzyme Technologies's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Enzyme Technologies (BOM:540025) Business Description

Traded in Other Exchanges
Address
Near LIC Service Road, Sun Magnetica, A Wing, 5th Floor, Louiswadi, Thane (West), Thane, MH, IND, 400604
Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The Company operates only in one business segment viz. manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.

Advanced Enzyme Technologies (BOM:540025) Headlines

No Headlines